News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Agenus has been granted a Type B End-of-Phase 2 meeting from the U.S. FDA
Photo taken from Agenus/LinkedIn
May 17, 2024, 11:18

Agenus has been granted a Type B End-of-Phase 2 meeting from the U.S. FDA

Agenus shared on LinkedIn:

“Today we announced that Agenus has been granted a Type B End-of-Phase 2 meeting from the U.S. FDA to discuss our botensilimab/balstilimab therapy for relapsed or refractory metastatic colorectal cancer.

Learn more.”

Source: Agenus/LinkedIn

Agenus Balstilimab botensilimab cancer FDA Metastatic colorectal cancer OncoDaily Oncology
Special Coverage
Blog
Apr 15, 2025, 12:23
Conquer Cancer - Julie Gralow discusses how aspiring grant makers can utilize grant management services
Societies
Apr 15, 2025, 12:21
The Pediatric Oncology East and Mediterranean Group's (POEM) 4th Scientific Meeting
Blog
Apr 15, 2025, 12:18
Erick Mahatara: Almost 75% deaths in the world are due to NCDs, and the urgency around these diseases still seems too low
Blog
Apr 15, 2025, 12:17
Bernard A. Fox: Great commentary from Nature Medicine on vaccine hesitancy and the threat presented by the new leadership of HHS
Blog
Apr 15, 2025, 12:17
Duke Radiation Oncology - Olivia Franek presenting radiation oncology patient education videos project at ONS Congress
Blog
Apr 15, 2025, 12:08
Luis Lara-Mejía: Oncogenic fusions represent a diagnostic challenge across solid tumors
Blog
Apr 15, 2025, 12:02
Early registration is closing for the ESMO Gynaecological Cancers 2025
Blog
Apr 15, 2025, 11:54
Esosa Omoregie: Day 2 at ASBMB 2025 - Insights, networking, and career growth
Blog
Apr 15, 2025, 11:52
Diego A. Díaz García: Updates on the treatment of EGFR-mutant NSCLC
Career
Apr 15, 2025, 11:46
Merel Hennink has been appointed to the Board of Lung Cancer Europe
Oncolibrary
Apr 15, 2025, 11:34
New Paper Alert: Insights from the PALMARES-2 Study: Improved Outcomes with Abemaciclib and Ribociclib in HR+/HER2- ABC
Blog
Apr 15, 2025, 11:34
Insightful updates and lively discussions at the EUonQoL General Assembly - European Cancer Organisation